Jeremy M. Levin - Dec 4, 2023 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
CEO, Director
Signature
/s/ Danielle Mann for Jeremy Levin PoA
Stock symbol
OVID
Transactions as of
Dec 4, 2023
Transactions value $
$0
Form type
4
Date filed
12/6/2023, 05:05 PM
Previous filing
Feb 27, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OVID Common Stock Gift $0 -573K -12.08% $0.00 4.17M Dec 4, 2023 Direct F1, F2
transaction OVID Common Stock Gift $0 -573K -13.74% $0.00 3.6M Dec 4, 2023 Direct F1
holding OVID Common Stock 35.5K Dec 4, 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The reporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares.
F2 This direct ownership total corrects an inadvertent administrative error in the number of shares of common stock that were reported as directly held on the Form 4 filed by the reporting executive on September 1, 2020. Before the transactions reported herein, the reporting executive held 4,745,017 shares of common stock directly
F3 The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The reporting executive's spouse is the manager of Divo. The reporting executive disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.